FTY720 modulates human oligodendrocyte progenitor process extension and survival
Article first published online: 4 OCT 2007
Copyright © 2007 American Neurological Association
Annals of Neurology
Volume 63, Issue 1, pages 61–71, January 2008
How to Cite
Miron, V. E., Jung, C. G., Kim, H. J., Kennedy, T. E., Soliven, B. and Antel, J. P. (2008), FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol., 63: 61–71. doi: 10.1002/ana.21227
- Issue published online: 29 JAN 2008
- Article first published online: 4 OCT 2007
- Manuscript Accepted: 3 AUG 2007
- Manuscript Revised: 29 JUN 2007
- Manuscript Received: 6 APR 2007
- Foundation of the Multiple Sclerosis Society of Canada
- Fondation de Reserche en Sante du Quebec
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
- National Institute of Neurological Disorders and Stroke. Grant Number: R21 NS049014
- National MS Society
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.